ACLARION, INC. Accounts Payable and Other Accrued Liabilities, Current
ACLARION, INC. (ACON) had Accounts Payable and Other Accrued Liabilities, Current of $379.12 thousand as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2023-11-14
- 2023-09-30: Accounts Payable and Other Accrued Liabilities, Current $379.12K.
- 2023-06-30: Accounts Payable and Other Accrued Liabilities, Current $513.00K.
- 2023-03-31: Accounts Payable and Other Accrued Liabilities, Current $736.41K.
- 2022-12-31: Accounts Payable and Other Accrued Liabilities, Current $226.47K; Accounts Payable and Other Accrued Liabilities, Current as first filed $1.07M.
| Period end | Accounts Payable and Other Accrued Liabilities, Current | Accounts Payable and Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2023-09-30 | $379.12K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $513.00K 10-Q · filed 2023-08-25 | |
| 2023-03-31 | $736.41K 10-Q · filed 2023-07-03 | |
| 2022-12-31 | $226.47K 10-Q · filed 2023-11-14 | $1.07M 10-K · filed 2023-02-27 |
| 2021-12-31 | $1.76M 10-K/A · filed 2023-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |